The GLP Journal

Comparisons

Side-by-side comparisons of GLP-1 telehealth options, with pricing.

• 

  Comparisons

  Semaglutide vs. Tirzepatide: What the Head-to-Head Trial Showed

  For three years the comparison was arithmetic across separate trials. SURMOUNT-5 put both drugs in the same study: 20.2% vs. 13.7% at 72 weeks. Plus the two places the lower number is still the better answer.

  7 min read · Updated Oct 10, 2026

• 

  Comparisons

  Wegovy Pill vs. Injection: How the Oral and Weekly Versions Compare

  The 25 mg Wegovy tablet reached pharmacies in January 2026. Same molecule as the injection — but a different daily routine, and two indications it does not carry.

  9 min read · Updated Oct 28, 2026

• 

  Comparisons

  LunaRx vs. Hims: GLP-1 Telehealth Compared

  How LunaRx's compounded, physician-directed program stacks up against Hims' GLP-1 offering — pricing, formulations, and support.

  9 min read · Updated Oct 5, 2026

• 

  Comparisons

  LunaRx vs. Ro: GLP-1 Telehealth Compared

  Pricing, formulations, and clinical approach — how LunaRx differs from Ro's GLP-1 program.

  9 min read · Updated Oct 5, 2026

• 

  Comparisons

  LunaRx vs. Nurx: GLP-1 Telehealth Compared

  A side-by-side of pricing, access, and clinical support between LunaRx and Nurx.

  9 min read · Updated Oct 5, 2026